Member Info for HedgeHogarth

Too many on here are obsessed with the SP.

True investors would look to put a realistic value on what the Company will be with over a 2/3 year horizon and base their investment in that.

Very tough to gauge the low here, a lot may depend on the timing and content of the next RNS.

Those looking to time in perfectly and hoping to get in sub 2p could be on to a winner. Then again, it may turn out that 2p is the bottom.

GLA

Comes across like a trader...

People were investing in Hemo when it was valued at £40m yet Tuan seems to think people won't invest when it's values at £10m.

Very difficult to ever buy in at the bottom. Hemo is not the only share to be more than 50% of its high right now...

Just my opinion, but things are nowhere near as bad as some like to make out here

No, Tuan says it as they see it. Very different, very naive at times..

People are buying in - the price has gone down because of the millions of shares dumped following CLNs

Tuan - full of ****e

Time with tell Ssccss...

GLA

Er... COVID has a habit of slowing things down...

It's Biotech, it can take time.

Progress has been made and clinical trials are next step

Ssccss....you are clueless fella....

Massive PR Issue with investors??? - in the last 6 to 8 weeks we have had 1, maybe 2 Vlad interviews which were well received

Opaque RNS??? They seem perfectly clear to me, i suggest you re-read them.

Impatient investors - yes, lots.

I douby any self respecting CEO would be a fan of 'traders'

The only bit we agree on is the CLNs, they have been the catalyst for the poor share price movement. I think its insane that the value of Hemogenys is approaching £10m - this is not way refelcts the IP, progress and potential of this company. Therfore I am very confident that the current SP is a short term issue - in time we will see a more realistic valuation. i cant put a timetable to this and is somewhat dependant on whether the company choose to pay back the CLNs.

However, the infestation of this board does give the impression that the sentiment is very negative towards Hemo. I do not belive this reflects the broader shareholder community - albeit many are pretty gutted about the recent SP falls.

Let the impatient sell - I'm holding.

Surprised we've not seen a TR-1 - a lot of shares have been bought and sold recently. Would not surprise me if someone is accumulating

MMs doing a nice job of picking up some shares today

Or is it starting to get exciting - feels like we are genuinely days/weeks away now lift off?

CJ - the most disgusting thing is your continued fascination and trolling on this BB.

There is no cult. You are simply goading a bunch of investors who believe in Hemo pipeline.

You clearly think you are better that everyone else. Well done. Well done if you timed this right.

But most of what you put in is is pure wind up material.

B1ll

Its pointless conversing with CJ Sterling. I'm afraid he is a low life troll who should have better things to do than hang around on this board - but alas not. Most just ignore him now.

Decent day for TOM. Some lucky investors would have had a chance to take 50% profits today, so that may explain a small retrace. (Given SP was c0.4p in the not too distance past)

GLA

Usual rubbish on see on here - this used to be a such a better, informative board before the haters - so much immaturity on here

Fortunately, what is said on this board will not affect Hemogenyx

If 29p was such a give away, I'd suggest the SP should be north of 29p now

Lay of the BOD, I don't see mayy BODs awarded options with a price premium of 20%+, often they are discounted.

ProcessGuy
All Hemo investors are well aware of the CLNs - my post was about the 6 product candidates.
Jog on

Onwards and upwards Hemo investors

This is why I am invested and will remain so - 6 (yes, SIX) product candidates,....

From today's Final Results:
"The last year has also seen the establishment of an exciting and flexible new platform technology that may be applied to create treatments for some forms of cancer and also for viruses such as SARS-CoV-2, the virus responsible for COVID-19. As a result, the pipeline has grown to a roster of six product candidates, compared to two when the Company first listed on the London Stock Exchange in 2017. This number is unusual for such a small company as Hemogenyx Pharmaceuticals."

Time to enjoy the bank holiday weekend

Boring Boring Tuan

This forum has got so boring - full of the same 'usual suspects' coming out with te same rubbish every day now...

Roll on some news from Vlad and the team - that way we can get back to talking aboyt the company rather than everyone obsessioning about te current SP.